ABT brings in $15M investment for market advancement
Producers of cyclotron and PET generator technologies ABT Molecular Imaging announced Oct. 20 that the company would be expanding into global markets with a $15 million boost in financing.
ABT, based in Knoxville, Tenn., will be gaining $10 million from SWK Holdings, a healthcare financing group, with an additional $5 million from a Series C cycle of funding.
“This infusion of capital is further affirmation of ABT’s unique proposition in the oncology market, and will enable us to access exciting new markets and develop our technology platform to better match significant untapped customer needs,” said ABT president and CEO Peter Kingma.